EWM
GNOM icon

Evolution Wealth Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Evolution Wealth Management’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.47K Hold
149
– – 0.01% 610
2026
Q1 		$6.52K Hold
149
– – ﹤0.01% 577
2025
Q4 		$6.77K Hold
149
– – 0.01% 495
2025
Q3 		$5.79K Hold
149
– – 0.01% 430
2025
Q2 		$5.02K Buy
+149
New +$4.72K 0.01% 449

Other funds holding GNOM

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return
SH
SLT Holdings Scottsdale, Arizona $160M AUM 52.3% 1-Year Est. Return
WMP
Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return
SWA
Sightline Wealth Advisors Groton, Connecticut $273M AUM 18.08% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $87.6B AUM 131.08% 1-Year Est. Return
AA
Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return
GIA
Gladstone Institutional Advisory Palm Beach Gardens, Florida $3.16B AUM 29.04% 1-Year Est. Return
JWCA
J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return
HHGA
Halbert Hargrove Global Advisors Long Beach, California $2.31B AUM 21.64% 1-Year Est. Return

Evolution Wealth Management's GNOM Position: Q2 2026 in Review

Evolution Wealth Management held its Global X Genomics & Biotechnology ETF (GNOM) position steady in Q2 2026 at 149 shares worth $8.47K. The position accounts for 0.01% of the portfolio, ranked #610.

Evolution Wealth Management first reported a position in GNOM in Q2 2025 and has held it in 5 quarters since. 17 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

  • Evolution Wealth Management held 149 shares of Global X Genomics & Biotechnology ETF worth $8.47K as of Q2 2026.
  • Evolution Wealth Management left its Global X Genomics & Biotechnology ETF share count unchanged in Q2 2026.
  • Global X Genomics & Biotechnology ETF made up 0.01% of Evolution Wealth Management's portfolio in Q2 2026, its #610 holding.
  • Evolution Wealth Management first reported a position in Global X Genomics & Biotechnology ETF in Q2 2025 and has held it in 5 quarters since.
  • 17 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on Evolution Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.